Rare Gene Mutation Could Galvanize Alzheimer’s Research
On Wednesday, scientists announced a finding that was published in the journal Nature. A single gene which causes the rare, early-onset form of Alzheimer’s disease can also carry a mutation that serves to protect against the disease. This mutation blocks the build-up of excess beta amyloid, and shows that beta amyloid is ‘the prime therapeutic target,’ says Rudy Tanzi, Chair of the Cure Alzheimer’s Fund Research Consortium.
Cure Alzheimer’s funded researcher Sam Gandy called the finding extraordinarily important, the most significant in the field since researchers first reported a mutation that leads to the disease 22 years ago.